anayamalik, Author at European Medical Journal - Page 72 of 83

Study Reveals High Risk of Preventable Surgery Errors

A new cohort study conducted across 11 U.S. hospitals has found that nearly 40% of surgical patients experience adverse events during inpatient perioperative care.

New Data on RSV Burden in U.S. Adults 75+

Respiratory syncytial virus (RSV) has caused severe illness in adults, especially among those aged 75 and older, but the burden of RSV-associated hospitalizations before vaccines were introduced is unclear.

CDC Appoints Industry To Develop Avian Flu Tests in New Agreement

An agreement has been issued by the United States Centers for Disease Control and Prevention (CDC) to partner with Alveo Technologies to develop a rapid, point-of-need diagnostic test for detecting avian influenza A(H5) in humans.

Prostate Cancer Overtreatment Among Veterans Persists

Overtreatment of prostate cancer persists among men with limited life expectancy within the Veterans Affairs (VA) health system.

The Teen Brain’s Secret Weapon Against Pain?

Resilience in adolescents with juvenile fibromyalgia (JFM) may significantly alleviate emotional symptoms, providing fresh insights for clinicians treating this complex chronic pain condition.

Clinical Implications of Metformin on COPD

Metformin, commonly prescribed for diabetes, may reduce the risks of exacerbation and hospitalization in patients with chronic obstructive pulmonary disease (COPD).

FDA Lifts Hold on COVID-Flu Combo Vaccine Trial

The U.S. Food and Drug Administration (FDA) has lifted a clinical hold on a late-stage trial of a combined COVID-19 and influenza vaccine candidate, allowing the study to resume following an investigation into a reported adverse event.

Emergency Department Costs: $207M and 2,143 Young Lives

A national study recently highlighted the potential life-saving impact of enhancing emergency departments’ (ED) pediatric readiness across the United States.

Annual DXA Screening “Essential” After Lung Transplant

A newly published study recommends annual DXA screenings for patients in the first 2 years after lung transplants to monitor bone mineral density (BMD) changes.

Rwanda Nears End of Marburg Outbreak

Rwanda has begun the 42-day countdown to officially declare an end to the Marburg virus outbreak, having discharged its last patient on November 8, 2024.